- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02393274
Microcirculation in Venoarterial Extracorporeal Membrane Oxygenation Life Support
April 19, 2018 updated by: National Taiwan University Hospital
Investigation of Microcirculation in Patients With Venoarterial Extracorporeal Membrane Oxygenation Life Support
Extra-corporeal membrane oxygenation (ECMO) life support system can provide both cardiac and respiratory support to patients with heart and respiratory failure.
It can save time for these organs to recovery or for these patients to receive further management.
However, many patients will die in spite of ECMO support.
One of the key factor is whether the blood flow provided by the ECMO can meet the requirement of organ perfusion.
The adequacy of macrocirculation may be determined by arterial pressure and minute blood flow of ECMO.
However, the adequacy of microcirculation remains as a major unresolved clinical problem.
This is a prospective observational clinical trial.
The sublingual microcirculation will be examined with the incident dark field video microscope within 6 hours after venoarterial ECMO placement, and then at 24 h, 48 h, 72 h, and 96 h.
The severity of multiple organ injury and clinical data will be recorded as well.
The major parameters of microcirculation include total small vessel density, perfused small vessel density, and microvascular flow index.
The sublingual microcirculation will also be examined before weaning off ECMO, within 6 hours after ECMO removal, and then at 24 h, 48 h, and 72 h.
Serum level of endothelial cell specific molecule-1 at specific time points will be examined.
The data of 14-day mortality, 28-day mortality, duration of ECMO support, and intensive care unit stay will be recorded.
This study aims primarily to investigate the relationship between microcirculation and prognosis of these patients.
This study will also investigate the relationship among serum level of endothelial cell specific molecule-1, microcirculation, and prognosis of these patients.
Wish the results of this study can be applied in further research to help to improve the quality of ECMO care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
48
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 79 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support
Description
Inclusion Criteria:
- Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support
Exclusion Criteria:
- who can not take an examination of sublingual microcirculation within 6 hours after placement of venoarterial ECMO support
- Non-native speakers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
28-day Survival
survive for at least 28 days after placement of extra-corporeal membrane oxygenation life support
|
venoarterial extra-corporeal membrane oxygenation life support
|
|
28-day Nonsurvival
not survive for 28 days after placement of extra-corporeal membrane oxygenation life support
|
venoarterial extra-corporeal membrane oxygenation life support
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perfused small vessel density
Time Frame: At enrollment (within 12 hour after placement of extra-corporeal membrane oxygenation life support)
|
Perfused small vessel density measured by incident dark field video microscope
|
At enrollment (within 12 hour after placement of extra-corporeal membrane oxygenation life support)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total small vessel density
Time Frame: At Enrollment
|
Total small vessel density measured by incident dark field video microscope
|
At Enrollment
|
|
Endocan level
Time Frame: At enrollment
|
At enrollment
|
|
|
Microvascular flow index
Time Frame: At enrollment
|
Microvascular flow index measured by incident dark field video microscope
|
At enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
March 15, 2015
First Submitted That Met QC Criteria
March 15, 2015
First Posted (Estimate)
March 19, 2015
Study Record Updates
Last Update Posted (Actual)
April 23, 2018
Last Update Submitted That Met QC Criteria
April 19, 2018
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201412045RINA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
Clinical Trials on Extra-corporeal membrane oxygenation life support
-
National Taiwan University HospitalCompletedCirculatory FailureTaiwan
-
Academisch Medisch Centrum - Universiteit van Amsterdam...WithdrawnOut-Of-Hospital Cardiac ArrestNetherlands
-
Maastricht University Medical CenterUnknownCardiac Surgery | Cardiogenic Shock | ResuscitationNetherlands
-
National Taiwan University HospitalCompletedRespiratory Failure | Cardiovascular ShockTaiwan
-
University Magna GraeciaNot yet recruitingAcute Respiratory Distress Syndrome | Acute Respiratory FailureItaly
-
Mahidol UniversityRecruitingSevere Acute Respiratory Distress Syndrome | Refractory HypoxemiaThailand
-
University Hospital, CaenTerminatedMyocardial Infarction | Shock, CardiogenicFrance
-
University of LeicesterUniversity of Tromso; KU Leuven; Ludwig-Maximilians - University of Munich; University... and other collaboratorsRecruitingCardiogenic ShockSpain, Germany, Belgium, United Kingdom, Austria, Italy, Latvia, Norway
-
Policlinico HospitalCompleted
-
LMU KlinikumCompleted